Juvenescence Therapeutics
Latest round
- Series B
Last raised
- May 2025
Total raised
- $162M
Investors
- 6
About Juvenescence Therapeutics
Founded in 2016, Juvenescence Therapeutics Limited specializes in the development of therapeutics aimed at extending health and life. The company is headquartered in Dublin, Ireland. Its CEO, Richard Marshall, has a background in founding other companies prior to establishing Juvenescence.000 mn.Juvenescence Therapeutics Limited offers a range of innovative therapeutics designed to tackle specific health challenges. Their flagship product provides advanced solutions tailored for efficiency and effectiveness, catering to a diverse clientele from small to medium-sized enterprises (SMEs) to large corporations.The company operates a revenue model based on direct-to-consumer sales and B2B partnerships. Clients access their solutions via a subscription-based service, providing continuous updates and support. Certain products are also available through licensing agreements, enabling businesses to integrate the technology into their operations. The company is also focused on expanding into new geographic markets, with efforts aimed at further penetrating North America and Europe by late 2026. Upcoming product launches are being designed to meet the evolving needs of the market, ensuring a robust pipeline going forward.
Who invested in Juvenescence Therapeutics
6 investors across 2 rounds
See all investors in Juvenescence Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Juvenescence Therapeutics
Who invested in Juvenescence Therapeutics?
Juvenescence Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Juvenescence Therapeutics raised?
Juvenescence Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Juvenescence Therapeutics last raise money?
Juvenescence Therapeutics's most recent round on record is a Series B, in May 2025.
What does Juvenescence Therapeutics do?
Founded in 2016, Juvenescence Therapeutics Limited specializes in the development of therapeutics aimed at extending health and life.
Where is Juvenescence Therapeutics headquartered?
Juvenescence Therapeutics is headquartered in Dublin, Ireland.
Which VCs invest in companies like Juvenescence Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Juvenescence Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Juvenescence Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.